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Vertebral osteoporotic/metastatic compression fractures cause
severe pain associated by immobility and therefore reduction
of quality of life which may result in depression.
Since conservative treatment has shown to be ineffective and
surgical treatment bearing risk of complications, percutaneous
techniques have been introduced for therapy. Vertebroplasty
was descripted first in 1987 in France by Galibet and Dera-
mond. Over the last ten years there has been significant devel-
opment in the therapeutic strategies for vertebral fractures using
vertebroplasty. Today this percutaneous procedure for relief of
back pain in selected patients is also costeffective when per-
formed by experienced interventionalists. Indication for verte-
broplasty include osteoporotic fractures and osteolytic changes
in the vertebral bodies caused by metastasis. Improvement of
technique and increased experience reduced the risk of com-
plications. The rate of pain relief reaches 90-95%, the rate of
complications from 0,5% (osteoporotic) to 2% (metastatic).
Degenerative changes of facet joints can be a source of back
pain. The goal of interventional percutaneous treatment by in-
jection of anesthetic and steroid drugs is to provide pain relief.
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